|
Monday, July 24, 2006
Ambrx Expands Series C
San Diego-based Ambrx has expanded its Series C round, announcing today that it has raised an additional $3M in venture funding. Financing came from the Scottish Widows Investment Partnership. The additional capital brings the firm's Series C round of funding to $55M. Ambrx said that the new funding will be used to further expand its novel protein modification platform, support the development of its product pipeline, and for general working capital purposes.
posted on Monday, July 24, 2006 (Link to more information)
|
 RSS
 Email
Twitter
Previous news:
Thursday, November 20, 2008
Wednesday, November 19, 2008
Tuesday, November 18, 2008
Monday, November 17, 2008
Friday, November 14, 2008
|
